Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer’s Disease
Soraya Herrera-Espejo, Borja Santos-Zorrozúa, Paula Álvarez‐González, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 12, pp. 8376-8391
Closed Access | Times Cited: 80

Showing 1-25 of 80 citing articles:

miR-212 and miR-132 Are Downregulated in Neurally Derived Plasma Exosomes of Alzheimer’s Patients
Jean‐Sébastien Diana, David Mengel, Maja Mustapić, et al.
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 173
Epigenetics of Alzheimer’s Disease
Matea Nikolac Perković, Alja Videtič Paska, Marcela Konjevod, et al.
Biomolecules (2021) Vol. 11, Iss. 2, pp. 195-195
Open Access | Times Cited: 130
Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence
Harald Hampel, Robert Nisticò, Nicholas T. Seyfried, et al.
Ageing Research Reviews (2021) Vol. 69, pp. 101346-101346
Closed Access | Times Cited: 107
Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline
Hanan Ehtewish, Abdelilah Arredouani, Omar M. A. El‐Agnaf
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 6144-6144
Open Access | Times Cited: 91
Mechanisms of mechanical overload-induced skeletal muscle hypertrophy: current understanding and future directions
Michael D. Roberts, John J. McCarthy, Troy A. Hornberger, et al.
Physiological Reviews (2023) Vol. 103, Iss. 4, pp. 2679-2757
Closed Access | Times Cited: 86
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer’s Disease
María Serpente, Chiara Fenoglio, Marianna D’Anca, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1443-1443
Open Access | Times Cited: 92
The promise of microRNA-based therapies in Alzheimer’s disease: challenges and perspectives
Hannah Walgrave, Lujia Zhou, Bart De Strooper, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 91
microRNA-132 regulates gene expression programs involved in microglial homeostasis
Hannah Walgrave, Amber Penning, Giorgia Tosoni, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106829-106829
Open Access | Times Cited: 24
Sex differences in the neuroinflammatory signaling pathway: effect of miRNAs on fatty acid synthesis in microglia
Haolin Zheng, Akiko Mizokami, Sergio Romera-Giner, et al.
Biology of Sex Differences (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Gene biomarker discovery at different stages of Alzheimer using gene co-expression network approach
Negar Sadat Soleimani Zakeri, Saeid Pashazadeh, Habib MotieGhader
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 61
miR‑132 improves the cognitive function of rats with Alzheimer's disease by inhibiting the MAPK1 signal pathway
Yiming Deng, Jingyu Zhang, Xuan Sun, et al.
Experimental and Therapeutic Medicine (2020) Vol. 20, Iss. 6
Open Access | Times Cited: 56
A microRNA signature that correlates with cognition and is a target against cognitive decline
Rezaul Islam, Lalit Kaurani, Tea Berulava, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 11
Open Access | Times Cited: 56
CRISPR/Cas13-Based Approaches for Ultrasensitive and Specific Detection of microRNAs
Javier T. Granados‐Riveron, Guillermo Aquino‐Jarquín
Cells (2021) Vol. 10, Iss. 7, pp. 1655-1655
Open Access | Times Cited: 51
Potential clinical value of circular RNAs as peripheral biomarkers for the diagnosis and treatment of major depressive disorder
Yachen Shi, Ruize Song, Zan Wang, et al.
EBioMedicine (2021) Vol. 66, pp. 103337-103337
Open Access | Times Cited: 47
Alzheimer’s Disease and microRNA-132: A Widespread Pathological Factor and Potential Therapeutic Target
Meng Zhang, Zhigang Bian
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 42
Multiomics technologies: role in disease biomarker discoveries and therapeutics
Mashooq Ahmad Dar, Azher Arafah, Kaisar Ahmad Bhat, et al.
Briefings in Functional Genomics (2022) Vol. 22, Iss. 2, pp. 76-96
Closed Access | Times Cited: 38
The Role of Epigenetics in Neuroinflammatory-Driven Diseases
Sebastiano Giallongo, Lucia Longhitano, Simona Denaro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15218-15218
Open Access | Times Cited: 33
Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer’s Disease
Devyani Bhatnagar, Shreya Ladhe, Dileep Kumar
Molecular Neurobiology (2023) Vol. 60, Iss. 10, pp. 5954-5974
Closed Access | Times Cited: 17
The role of microRNAs in understanding sex-based differences in Alzheimer’s disease
Jaime Llera-Oyola, Héctor Carceller, Zoraida Andreu, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
LncRNA NEAT1 Regulates the Development of Parkinson’s Disease by Targeting AXIN1 Via Sponging miR-212-3p
Tao Liu, Yang Zhang, Weihong Liu, et al.
Neurochemical Research (2020) Vol. 46, Iss. 2, pp. 230-240
Closed Access | Times Cited: 41
Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer’s Disease Using Post-mortem Brain Tissue Samples
Qingqin S. Li, Diana Cai
Frontiers in Neuroscience (2021) Vol. 15
Open Access | Times Cited: 38
The microRNA Lifecycle in Health and Cancer
Laura Adriana de Rooij, Dirk Jan Mastebroek, Nicky ten Voorde, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5748-5748
Open Access | Times Cited: 27
Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood–Brain Barrier Crossing Ability
Qingting Song, Junyou Li, Ting Li, et al.
Advanced Science (2024) Vol. 11, Iss. 38
Open Access | Times Cited: 6
Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia
Virginie Bottero, Judith A. Potashkin
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 21, pp. 5403-5403
Open Access | Times Cited: 40
miR-212-3p attenuates neuroinflammation of rats with Alzheimer's disease via regulating the SP1/BACE1/NLRP3/Caspase-1 signaling pathway
Wei Nong, Chuanhong Bao, Yixin Chen, et al.
Bosnian Journal of Basic Medical Sciences (2022)
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top